The recombinant lectin-like domain of thrombomodulin inhibits angiogenesis through interaction with Lewis Y antigen

Blood

Volumn 119, Issue 5, 2012, Pages 1302-1313

  Kuo, Cheng Hsiang ^a   Chen, Po Ku ^a   Chang, Bi Ing ^a   Sung, Meng Chen ^a   Shi, Chung Sheng ^a   Lee, Jeng Shin ^b   Chang, Chuan Fa ^a   Shi, Guey Yueh ^a   Wu, Hua Lin ^a,c  

^a NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

^b HARVARD MEDICAL SCHOOL   (United States)

^c NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; BLOOD GROUP ANTIGEN; EPIDERMAL GROWTH FACTOR RECEPTOR; LECTIN; LEWIS Y ANTIGEN; MATRIGEL; MEMBRANE ANTIGEN; RECOMBINANT PROTEIN; THROMBOMODULIN; UNCLASSIFIED DRUG;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIANGIOGENIC ACTIVITY; ARTICLE; BIOLOGICAL FUNCTIONS; CARCINOGENESIS; CHEMOTAXIS; CONTROLLED STUDY; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; RAT; SIGNAL TRANSDUCTION;

EID: 84863011918     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2011-08-376038     Document Type: Article

References (47)

1. Carmeliet P. Angiogenesis in life, disease and medicine. Nature. 2005;438(7070):932-936. (Pubitemid 43093958)
2. Suzuki K, Kusumoto H, Deyashiki Y, et al. Structure and expression of human thrombomodulin, a thrombin receptor on endothelium acting as a cofactor for protein C activation. EMBO J. 1987;6(7):1891-1897.
3. Ishii H, Uchiyama H, Kazama M. Soluble thrombomodulin antigen in conditioned medium is increased by damage of endothelial cells. Thromb Haemost. 1991;65(5):618-623.
4. Ishii H, Majerus PW. Thrombomodulin is present in human plasma and urine. J Clin Invest. 1985;76(6):2178-2181. (Pubitemid 16155511)
5. Jackson DE, Tetaz TJ, Salem HH, Mitchell CA. Purification and characterization of two forms of soluble thrombomodulin from human urine. Eur J Biochem. 1994;221(3):1079-1087. (Pubitemid 24146211)
6. Uehara S, Gotoh K, Handa H. Separation and characterization of the molecular species of thrombomodulin in the plasma of diabetic patients. Thromb Res. 2001;104(5):325-332. (Pubitemid 33152953)
7. Shi CS, Shi GY, Chang YS, et al. Evidence of human thrombomodulin domain as a novel angiogenic factor. Circulation. 2005;111(13):1627-1636.
8. Conway EM, Van de Wouwer M, Pollefeyt S, et al. The lectin-like domain of thrombomodulin confers protection from neutrophil-mediated tissue damage by suppressing adhesion molecule expression via nuclear factor kappaB and mitogen-activated protein kinase pathways. J Exp Med. 2002;196(5):565-577. (Pubitemid 35024436)
9. Abeyama K, Stern DM, Ito Y, et al. The N-terminal domain of thrombomodulin sequesters high-mobility group-B1 protein, a novel antiinflammatory mechanism. J Clin Invest. 2005;115(5):1267-1274. (Pubitemid 40629045)
10. Van de Wouwer M, Plaisance S, De Vriese A, et al. The lectin-like domain of thrombomodulin interferes with complement activation and protects against arthritis. J Thromb Haemost. 2006;4(8):1813-1824. (Pubitemid 44144810)
11. Shi CS, Shi GY, Hsiao SM, et al. Lectin-like domain of thrombomodulin binds to its specific ligand Lewis Y antigen and neutralizes lipopoly-saccharide-induced inflammatory response. Blood. 2008;112(9):3661-3670.
12. Holgersson J, Breimer ME, Samuelsson BE. Basic biochemistry of cell surface carbohydrates and aspects of the tissue distribution of histoblood group ABH and related glycosphingolipids. APMIS Suppl. 1992;27:18-27.
13. Basu A, Murthy U, Rodeck U, Herlyn M, Mattes L, Das M. Presence of tumor-associated antigens in epidermal growth factor receptors from different human carcinomas. Cancer Res. 1987;47(10):2531-2536. (Pubitemid 17083135)
14. Yin BW, Finstad CL, Kitamura K, et al. Serological and immunochemical analysis of Lewis y (Ley) blood group antigen expression in epithelial ovarian cancer. Int J Cancer. 1996;65(4):406-412.
15. Halloran MM, Carley WW, Polverini PJ, et al. Ley/H: an endothelial-selective, cytokine-inducible, angiogenic mediator. J Immunol. 2000;164(9):4868-4877. (Pubitemid 30238091)
16. Garcia-Vallejo JJ, van Liempt E, da Costa Martins P, et al. DC-SIGN mediates adhesion and rolling of dendritic cells on primary human umbilical vein endothelial cells through LewisY antigen expressed on ICAM-2. Mol Immunol. 2008;45(8):2359-2369.
17. Le Pendu J, Marionneau S, Cailleau-Thomas A, Rocher J, Le Moullac-Vaidye B, Clement M. ABH and Lewis histo-blood group antigens in cancer. APMIS. 2001;109(1):9-31. (Pubitemid 32243471)
18. Moehler TM, Sauer S, Witzel M, et al. Involvement of alpha 1-2-fucosyltransferase I (FUT1) and surface-expressed Lewis(y) (CD174) in first endothelial cell-cell contacts during angiogenesis. J Cell Physiol. 2008;215(1):27-36. (Pubitemid 351363188)
19. Huang HC, Shi GY, Jiang SJ, et al. Thrombomodulin-mediated cell adhesion: involvement of its lectin-like domain. J Biol Chem. 2003;278(47):46750-46759.
20. Xiao X, Li J, Samulski RJ. Production of high-titer recombinant adeno-associated virus vectors in the absence of helper adenovirus. J Virol. 1998;72(3):2224-2232. (Pubitemid 28100780)
21. Fournier GA, Lutty GA, Watt S, Fenselau A, Patz A. A corneal micropocket assay for angiogenesis in the rat eye. Invest Ophthalmol Vis Sci. 1981;21(2):351-354. (Pubitemid 11061891)
22. Kenyon BM, Voest EE, Chen CC, Flynn E, Folkman J, D'Amato RJ. A model of angiogenesis in the mouse cornea. Invest Ophthalmol Vis Sci. 1996;37(8):1625-1632. (Pubitemid 26271414)
23. Rogers MS, Birsner AE, D'Amato RJ. The mouse cornea micropocket angiogenesis assay. Nat Protoc. 2007;2(10):2545-2550.
24. Weidner N, Semple JP, Welch WR, Folkman J. Tumor angiogenesis and metastasis-correlation in invasive breast carcinoma. N Engl J Med. 1991;324(1):1-8.
25. Klinger M, Farhan H, Just H, et al. Antibodies directed against Lewis-Y antigen inhibit signaling of Lewis-Y modified ErbB receptors. Cancer Res. 2004;64(3):1087-1093. (Pubitemid 38176914)
26. Schreiber AB, Winkler ME, Derynck R. Transforming growth factor-alpha: a more potent angiogenic mediator than epidermal growth factor. Science. 1986;232(4755):1250-1253. (Pubitemid 16066000)
27. Yarden Y, Sliwkowski MX. Untangling the ErbB signalling network. Nat Rev Mol Cell Biol. 2001;2(2):127-137. (Pubitemid 33674041)
28. Bergers G, Benjamin LE. Tumorigenesis and the angiogenic switch. Nat Rev Cancer. 2003;3(6):401-410. (Pubitemid 37328844)
29. Heilbronn R, Weger S. Viral vectors for gene transfer: current status of gene therapeutics. Handb Exp Pharmacol. 2010;(197):143-170.
30. Gray A, Dull TJ, Ullrich A. Nucleotide sequence of epidermal growth factor cDNA predicts a 128,000-molecular weight protein precursor. Nature. 1983;303(5919):722-725. (Pubitemid 13106742)
31. O'Reilly MS, Holmgren L, Shing Y, et al. Angiostatin: a novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma. Cell. 1994;79(2):315-328. (Pubitemid 24324921)
32. Taraboletti G, Morbidelli L, Donnini S, et al. The heparin binding 25 kDa fragment of thrombospondin-1 promotes angiogenesis and modulates gelatinase and TIMP-2 production in endothelial cells. FASEB J. 2000;14(12):1674-1676.
33. Ileri M, Hisar I, Yetkin E, et al. Increased levels of plasma thrombomodulin in patients with acute myocardial infarction who had thrombolytic therapy and achieved successful reperfusion. Clin Cardiol. 2001;24(5):377-379. (Pubitemid 32391197)
34. Iba T, Yagi Y, Kidokoro A, Fukunaga M, Fukunaga T. Increased plasma levels of soluble thrombomodulin in patients with sepsis and organ failure. Surg Today. 1995;25(7):585-590.
35. Chan SH, Chen JH, Li YH, Lin LJ, Tsai LM. Increasing post-event plasma thrombomodulin level associates with worse outcome in survival of acute coronary syndrome. Int J Cardiol. 2006;111(2):280-285.
36. Tohda G, Oida K, Okada Y, et al. Expression of thrombomodulin in atherosclerotic lesions and mitogenic activity of recombinant thrombomodulin in vascular smooth muscle cells. Arterioscler Thromb Vasc Biol. 1998;18(12):1861-1869. (Pubitemid 28565747)
37. Hamada H, Ishii H, Sakyo K, Horie S, Nishiki K, Kazama M. The epidermal growth factor-like domain of recombinant human thrombomodulin exhibits mitogenic activity for Swiss 3T3 cells. Blood. 1995;86(1):225-233.
38. Ballmer K, Burger MM. Modulation of EGF binding and action by succinylated concanavalin A in fibroblast cell cultures. J Supramol Struct. 1980;14(2):209-214. (Pubitemid 11110665)
39. Zeng FY, Benguria A, Kafert S, Andre S, Gabius HJ, Villalobo A. Differential response of the epidermal growth factor receptor tyrosine kinase activity to several plant and mammalian lectins. Mol Cell Biochem. 1995;142(2):117-124.
40. Farhan H, Schuster C, Klinger M, et al. Inhibition of xenograft tumor growth and down-regulation of ErbB receptors by an antibody directed against Lewis Y antigen. J Pharmacol Exp Ther. 2006;319(3):1459-1466.
41. Boffa MC, Burke B, Haudenschild CC. Preservation of thrombomodulin antigen on vascular and extravascular surfaces. J Histochem Cytochem. 1987;35(11):1267-1276.
42. Healy AM, Rayburn HB, Rosenberg RD, Weiler H. Absence of the blood-clotting regulator thrombomodulin causes embryonic lethality in mice before development of a functional cardiovascular system. Proc Natl Acad Sci U S A. 1995;92(3):850-854.
43. Hanly AM, Winter DC. The role of thrombomodulin in malignancy. Semin Thromb Hemost. 2007;33(7):673-679. (Pubitemid 350157011)
44. Iino S, Abeyama K, Kawahara K, et al. The antimetastatic role of thrombomodulin expression in islet cell-derived tumors and its diagnostic value. Clin Cancer Res. 2004;10(18 Pt 1):6179-6188. (Pubitemid 39287524)
45. Horowitz NA, Blevins EA, Miller WM, et al. Thrombomodulin is a determinant of metastasis through a mechanism linked to the thrombin binding domain but not the lectin-like domain. Blood. 2011;118(10):2889-2895.
46. Hosaka Y, Higuchi T, Tsumagari M, Ishii H. Inhibition of invasion and experimental metastasis of murine melanoma cells by human soluble thrombomodulin. Cancer Lett. 2000;161(2):231-240.
47. Wu HL, Lin CI, Huang YL, et al. Lysophosphatidic acid stimulates thrombomodulin lectin-like domain shedding in human endothelial cells. Biochem Biophys Res Commun. 2008;367(1):162-168.